Paul Sargeant, CEO of Circular Genomics, joins Water Tower Research’s Shawn Severson and Robert Sassoon on the Healthcare Happenings podcast to discuss circular RNA science, the company’s product pipeline and out-licensing strategy, its depression assay and planned late-2026 Alzheimer’s RUO launch, a systems-level approach beyond amyloid and tau, and the company's commercialization strategy.